Internal Medicine, Hematology & Oncology · Johns Creek, GA
NPI
1780662361
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
6300 Hospital Pkwy, Suite 300
Johns Creek, GA, 30097
Phone (770) 623-8965
Groups this clinician bills Medicare through
Medicare paid, 2024
$79K
1,109 services
Medicare patients, 2024
372
Average age 73
Drug cost, 2024
$4.1M
2,582 prescriptions
Company payments, 2025
$1,328
From 21 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Stephen M Szabo was code 99214 (office e&m - established), 406 times for 160 patients. In total Stephen M Szabo billed 1,109 services in 11 codes, and Medicare paid $79K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-04-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 406 | 160 | $74.25 | $30K |
| 99213 Office E&M - Established | Facility | 225 | 174 | $50.90 | $11K |
| 99214 Office E&M - Established | Office | 178 | 94 | $79.40 | $14K |
| 99213 Office E&M - Established | Office | 93 | 91 | $52.69 | $4,900 |
| 99204 Office E&M - New | Facility | 43 | 43 | $99.83 | $4,293 |
| 36415 Venipuncture Blood Collection | Office | 35 | 34 | $8.45 | $296 |
| 99222 Hospital E&M - Initial | Facility | 34 | 32 | $98.37 | $3,344 |
| 99215 Office E&M - Established | Facility | 30 | 22 | $112.21 | $3,366 |
| 99204 Office E&M - New | Office | 16 | 16 | $122.08 | $1,953 |
| 99215 Office E&M - Established | Office | 14 | 12 | $123.34 | $1,727 |
| 99223 Hospital E&M - Initial | Facility | 13 | 13 | $134.57 | $1,749 |
By year: 2022 $88K for 1,740 services; 2023 $83K for 1,068 services; 2024 $79K for 1,109 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 35 | 34 | $8.45 | $296 |
Medicare prescription drug claims, 2024
In 2024, the drug Stephen M Szabo prescribed most often to Medicare patients was Eliquis (Apixaban), with 190 prescriptions and refills. In total Stephen M Szabo wrote 2,582 Medicare prescriptions that cost $4.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eliquis Apixaban | 190 | 340 | 49 | $197K |
| Anastrozole Generic | 177 | 440 | 48 | $2,420 |
| Ondansetron Hcl Generic | 150 | 150 | 84 | $2,294 |
| Prochlorperazine Maleate Generic | 127 | 127 | 71 | $1,099 |
| Oxycodone Hcl Generic | 115 | 115 | 49 | $2,018 |
| Gabapentin Generic | 110 | 162 | 33 | $843 |
| Lidocaine-Prilocaine Lidocaine/Prilocaine | 92 | 93 | 61 | $1,111 |
| Letrozole Generic | 87 | 210 | 26 | $1,540 |
| Xarelto Rivaroxaban | 85 | 145 | 20 | $80K |
| Prednisone Generic | 57 | 57 | 35 | $142 |
| Dexamethasone Generic | 54 | 58 | 23 | $780 |
| Hydroxyurea Generic | 51 | 101 | 13 | $943 |
| Megestrol Acetate Generic | 46 | 50 | 26 | $3,663 |
| Tramadol Hcl Generic | 45 | 45 | 25 | $308 |
| Doxycycline Hyclate Generic | 42 | 42 | 33 | $360 |
Brand drugs: - claims; generic drugs: 1,992 claims; opioid claims: 206.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Stephen M Szabo $1,328 ($1,328 in general payments such as food, travel and fees) from 21 companies. The largest payer was Pfizer Inc. with $152.
| Company | Payments | Amount |
|---|---|---|
| Pfizer Inc. PFE | 7 | $152 |
| Novartis Pharmaceuticals Corporation NVS | 6 | $147 |
| Merck Sharp & Dohme LLC MRK | 5 | $130 |
| AstraZeneca Pharmaceuticals LP AZN | 4 | $105 |
| Sanofi-Aventis U.S. LLC SNY | 1 | $99 |
| Daiichi Sankyo Inc. 4568.T | 3 | $83.08 |
| Gilead Sciences, Inc. GILD | 3 | $80.4 |
| Abbvie Inc. ABBV | 3 | $79.57 |
| Eisai Inc. 4523.T | 3 | $64.98 |
| GlaxoSmithKline, LLC. GSK | 3 | $56.23 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.